US 7,063,857 B1Granted

Use of macrolide compounds for the treatment of dry eye

AssigneeSucampo AG

InventorRyuji Ueno

Life of this patent

Estimating the term…

Abstract

The present invention provides an agent for treating a dry eye, which contains a macrolide compound such as FK506.

Claims9

Dependent claims

A method for treating a dry eye, comprising ocular administration of an effective amount of a macrolide compound to a subject in need of the treatment of dry eye.

Dependencies are inferred from the claim text.

Facts

Application: 09/926,411Filed 26 Apr 2000 · us provisional application
Priority: 30 Apr 1999
Granted: 20 Jun 2006
Term ends: Not estimatedThe source records don’t support an estimate.

Classification4 codes

A61K 31/4745
Ortho- or peri-condensed with heterocyclic ring systems: condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
A61K 31/407
Having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil: condensed with other…
A61K 31/436
Ortho- or peri-condensed with heterocyclic ring systems: the heterocyclic ring system containing a six-membered ring having oxygen as a ring…
A61K
Medicines and medical preparations

Family

Application60/132,009Us provisional application · filed 30 Apr 1999
US 7,063,857 B1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results